Intravitreal bevacizumab injection for chronic central serous chorioretinopathy.
- Author:
Xiu-juan LI
1
;
Jin-song ZHANG
Author Information
1. Department of Ophthalmology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China. yankeyisheng@yeah.net
- Publication Type:Case Reports
- MeSH:
Adult;
Angiogenesis Inhibitors;
administration & dosage;
therapeutic use;
Antibodies, Monoclonal;
administration & dosage;
therapeutic use;
Antibodies, Monoclonal, Humanized;
Bevacizumab;
Central Serous Chorioretinopathy;
drug therapy;
Humans;
Intravitreal Injections;
methods;
Male
- From:
Chinese Medical Journal
2010;123(15):2145-2147
- CountryChina
- Language:English
